- Home
- NBY vs TCRT Comparison
NBY vs TCRT Comparison
Compare NBY & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- TCRT
- Stock Information
- Founded
- NBY 2000
- TCRT 1998
- Country
- NBY United States
- TCRT United States
- Employees
- NBY N/A
- TCRT N/A
- Industry
- NBY
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- TCRT Health Care
- Exchange
- NBY Nasdaq
- TCRT Nasdaq
- Market Cap
- NBY 3.4M
- TCRT 3.8M
- IPO Year
- NBY 2007
- TCRT N/A
- Fundamental
- Price
- NBY $0.58
- TCRT $3.03
- Analyst Decision
- NBY Strong Buy
- TCRT
- Analyst Count
- NBY 1
- TCRT 0
- Target Price
- NBY $0.85
- TCRT N/A
- AVG Volume (30 Days)
- NBY 41.7K
- TCRT 12.3K
- Earning Date
- NBY 05-15-2025
- TCRT 05-15-2025
- Dividend Yield
- NBY N/A
- TCRT N/A
- EPS Growth
- NBY N/A
- TCRT N/A
- EPS
- NBY 0.57
- TCRT N/A
- Revenue
- NBY $9,781,000.00
- TCRT $11,000.00
- Revenue This Year
- NBY $23.91
- TCRT $5,680,500.00
- Revenue Next Year
- NBY $32.05
- TCRT N/A
- P/E Ratio
- NBY $1.27
- TCRT N/A
- Revenue Growth
- NBY 20.52
- TCRT 83.33
- 52 Week Low
- NBY $0.36
- TCRT $1.31
- 52 Week High
- NBY $3.15
- TCRT $11.00
- Technical
- Relative Strength Index (RSI)
- NBY 52.01
- TCRT 60.98
- Support Level
- NBY $0.55
- TCRT $2.50
- Resistance Level
- NBY $0.61
- TCRT $2.80
- Average True Range (ATR)
- NBY 0.02
- TCRT 0.21
- MACD
- NBY 0.00
- TCRT 0.01
- Stochastic Oscillator
- NBY 50.00
- TCRT 98.31
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.